Annual CAPEX
$523.00 K
-$39.53 M-98.69%
December 31, 2024
Summary
- As of March 7, 2025, ACAD annual capital expenditures is $523.00 thousand, with the most recent change of -$39.53 million (-98.69%) on December 31, 2024.
- During the last 3 years, ACAD annual CAPEX has fallen by -$599.00 thousand (-53.39%).
- ACAD annual CAPEX is now -98.69% below its all-time high of $40.05 million, reached on December 31, 2023.
Performance
ACAD CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$453.00 K
+$383.00 K+547.14%
December 31, 2024
Summary
- As of March 7, 2025, ACAD quarterly capital expenditures is $453.00 thousand, with the most recent change of +$383.00 thousand (+547.14%) on December 31, 2024.
- Over the past year, ACAD quarterly CAPEX has increased by +$453.00 thousand (+100.00%).
- ACAD quarterly CAPEX is now -98.87% below its all-time high of $40.00 million, reached on June 30, 2023.
Performance
ACAD Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$523.00 K
+$453.00 K+647.14%
December 31, 2024
Summary
- As of March 7, 2025, ACAD TTM capital expenditures is $523.00 thousand, with the most recent change of +$453.00 thousand (+647.14%) on December 31, 2024.
- Over the past year, ACAD TTM CAPEX has dropped by -$39.53 million (-98.69%).
- ACAD TTM CAPEX is now -98.69% below its all-time high of $40.05 million, reached on September 30, 2023.
Performance
ACAD TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ACAD CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -98.7% | +100.0% | -98.7% |
| 3 y3 years | -53.4% | +10000.0% | -53.4% |
| 5 y5 years | -53.7% | +118.8% | -53.7% |
ACAD CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.7% | at low | -98.9% | -100.0% | -98.7% | +647.1% |
| 5 y | 5-year | -98.7% | at low | -98.9% | -100.0% | -98.7% | +647.1% |
| alltime | all time | -98.7% | >+9999.0% | -98.9% | -100.0% | -98.7% | >+9999.0% |
ACADIA Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $523.00 K(-98.7%) | $453.00 K(+547.1%) | $523.00 K(+647.1%) |
| Sep 2024 | - | $70.00 K(>+9900.0%) | $70.00 K(-99.8%) |
| Dec 2023 | $40.05 M(+3469.5%) | $0.00(-100.0%) | $40.05 M(0.0%) |
| Sep 2023 | - | $50.00 K(-99.9%) | $40.05 M(+0.1%) |
| Jun 2023 | - | $40.00 M(>+9900.0%) | $40.00 M(+3465.1%) |
| Dec 2021 | $1.12 M(-85.2%) | $1000.00(>+9900.0%) | $1.12 M(-64.0%) |
| Sep 2021 | - | $0.00(-100.0%) | $3.12 M(-35.6%) |
| Jun 2021 | - | $45.00 K(-95.8%) | $4.84 M(-37.4%) |
| Mar 2021 | - | $1.08 M(-46.2%) | $7.73 M(+1.9%) |
| Dec 2020 | $7.59 M(+572.0%) | $2.00 M(+16.2%) | $7.59 M(+30.9%) |
| Sep 2020 | - | $1.72 M(-41.3%) | $5.79 M(+39.5%) |
| Jun 2020 | - | $2.93 M(+214.0%) | $4.15 M(+234.7%) |
| Mar 2020 | - | $934.00 K(+351.2%) | $1.24 M(+9.9%) |
| Dec 2019 | $1.13 M(-46.3%) | $207.00 K(+158.8%) | $1.13 M(-22.0%) |
| Sep 2019 | - | $80.00 K(+300.0%) | $1.45 M(-39.2%) |
| Jun 2019 | - | $20.00 K(-97.6%) | $2.38 M(-3.8%) |
| Mar 2019 | - | $822.00 K(+56.3%) | $2.48 M(+17.8%) |
| Dec 2018 | $2.10 M(+159.1%) | $526.00 K(-48.2%) | $2.10 M(+32.7%) |
| Sep 2018 | - | $1.01 M(+782.6%) | $1.58 M(+153.2%) |
| Jun 2018 | - | $115.00 K(-74.3%) | $626.00 K(-19.2%) |
| Mar 2018 | - | $448.00 K(+6300.0%) | $775.00 K(-4.6%) |
| Dec 2017 | $812.00 K(-91.5%) | $7000.00(-87.5%) | $812.00 K(-23.0%) |
| Sep 2017 | - | $56.00 K(-78.8%) | $1.05 M(-28.2%) |
| Jun 2017 | - | $264.00 K(-45.6%) | $1.47 M(-85.0%) |
| Mar 2017 | - | $485.00 K(+94.8%) | $9.78 M(+2.9%) |
| Dec 2016 | $9.51 M(+344.0%) | $249.00 K(-47.0%) | $9.51 M(-0.5%) |
| Sep 2016 | - | $470.00 K(-94.5%) | $9.55 M(+3.1%) |
| Jun 2016 | - | $8.58 M(+4044.9%) | $9.27 M(+581.3%) |
| Mar 2016 | - | $207.00 K(-29.4%) | $1.36 M(-36.5%) |
| Dec 2015 | $2.14 M(+1089.4%) | $293.00 K(+57.5%) | $2.14 M(+10.2%) |
| Sep 2015 | - | $186.00 K(-72.4%) | $1.94 M(+5.8%) |
| Jun 2015 | - | $674.00 K(-31.8%) | $1.84 M(+58.0%) |
| Mar 2015 | - | $988.00 K(+951.1%) | $1.16 M(+545.6%) |
| Dec 2014 | $180.00 K | $94.00 K(+17.5%) | $180.00 K(-15.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | - | $80.00 K(>+9900.0%) | $214.00 K(-61.1%) |
| Jun 2014 | - | $0.00(-100.0%) | $550.00 K(-11.9%) |
| Mar 2014 | - | $6000.00(-95.3%) | $624.00 K(+1.0%) |
| Dec 2013 | $618.00 K(>+9900.0%) | $128.00 K(-69.2%) | $618.00 K(+26.1%) |
| Sep 2013 | - | $416.00 K(+462.2%) | $490.00 K(+562.2%) |
| Jun 2013 | - | $74.00 K(>+9900.0%) | $74.00 K(+2366.7%) |
| Dec 2011 | $3000.00(-92.7%) | $0.00(-100.0%) | $3000.00(0.0%) |
| Sep 2011 | - | $3000.00(-82.4%) | $3000.00(-92.7%) |
| Dec 2009 | $41.00 K(-81.9%) | $17.00 K(0.0%) | $41.00 K(+32.3%) |
| Sep 2009 | - | $17.00 K(+750.0%) | $31.00 K(-61.7%) |
| Jun 2009 | - | $2000.00(-60.0%) | $81.00 K(-47.4%) |
| Mar 2009 | - | $5000.00(-28.6%) | $154.00 K(-31.9%) |
| Dec 2008 | $226.00 K(-45.7%) | $7000.00(-89.6%) | $226.00 K(-20.1%) |
| Sep 2008 | - | $67.00 K(-10.7%) | $283.00 K(-24.1%) |
| Jun 2008 | - | $75.00 K(-2.6%) | $373.00 K(-11.8%) |
| Mar 2008 | - | $77.00 K(+20.3%) | $423.00 K(+1.7%) |
| Dec 2007 | $416.00 K(-79.5%) | $64.00 K(-59.2%) | $416.00 K(-59.7%) |
| Sep 2007 | - | $157.00 K(+25.6%) | $1.03 M(-20.3%) |
| Jun 2007 | - | $125.00 K(+78.6%) | $1.29 M(-31.7%) |
| Mar 2007 | - | $70.00 K(-89.7%) | $1.90 M(-6.4%) |
| Dec 2006 | $2.03 M(+98.2%) | $680.00 K(+61.9%) | $2.03 M(+28.5%) |
| Sep 2006 | - | $420.00 K(-42.2%) | $1.58 M(+7.4%) |
| Jun 2006 | - | $727.00 K(+265.3%) | $1.47 M(+29.9%) |
| Mar 2006 | - | $199.00 K(-13.9%) | $1.13 M(+10.6%) |
| Dec 2005 | $1.02 M(+74.7%) | $231.00 K(-25.7%) | $1.02 M(+3.1%) |
| Sep 2005 | - | $311.00 K(-20.1%) | $990.80 K(+29.6%) |
| Jun 2005 | - | $389.00 K(+327.5%) | $764.60 K(+20.6%) |
| Mar 2005 | - | $91.00 K(-54.5%) | $634.20 K(+8.4%) |
| Dec 2004 | $585.00 K(-67.1%) | $199.80 K(+135.6%) | $585.00 K(+51.9%) |
| Sep 2004 | - | $84.80 K(-67.2%) | $385.20 K(+28.2%) |
| Jun 2004 | - | $258.60 K(+518.7%) | $300.40 K(+618.7%) |
| Mar 2004 | - | $41.80 K | $41.80 K |
| Dec 2003 | $1.78 M(+367.0%) | - | - |
| Dec 2002 | $380.60 K | - | - |
FAQ
- What is ACADIA Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual CAPEX year-on-year change?
- What is ACADIA Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly CAPEX year-on-year change?
- What is ACADIA Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals TTM CAPEX year-on-year change?
What is ACADIA Pharmaceuticals annual capital expenditures?
The current annual CAPEX of ACAD is $523.00 K
What is the all time high annual CAPEX for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual capital expenditures is $40.05 M
What is ACADIA Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, ACAD annual capital expenditures has changed by -$39.53 M (-98.69%)
What is ACADIA Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of ACAD is $453.00 K
What is the all time high quarterly CAPEX for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly capital expenditures is $40.00 M
What is ACADIA Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, ACAD quarterly capital expenditures has changed by +$453.00 K (+100.00%)
What is ACADIA Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of ACAD is $523.00 K
What is the all time high TTM CAPEX for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high TTM capital expenditures is $40.05 M
What is ACADIA Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, ACAD TTM capital expenditures has changed by -$39.53 M (-98.69%)